394 related articles for article (PubMed ID: 28538702)
21. Contribution of the (1-->3)-beta-D-glucan assay for diagnosis of invasive fungal infections.
Persat F; Ranque S; Derouin F; Michel-Nguyen A; Picot S; Sulahian A
J Clin Microbiol; 2008 Mar; 46(3):1009-13. PubMed ID: 18160456
[TBL] [Abstract][Full Text] [Related]
22. Early diagnosis and treatment of invasive aspergillosis as a main determinant of outcome - review of literature according to the presented case report.
Borys M; Piwowarczyk P; Sysiak J; Czuczwar M; Prystupa A
Ann Agric Environ Med; 2017 Mar; 24(1):100-103. PubMed ID: 28378982
[TBL] [Abstract][Full Text] [Related]
23. Comparative evaluation of pan-fungal real-time PCR, galactomannan and (1-3)-β-D-glucan assay for invasive fungal infection in paediatric cancer patients.
Gupta P; Ahmad A; Khare V; Kumar A; Banerjee G; Verma N; Singh M
Mycoses; 2017 Apr; 60(4):234-240. PubMed ID: 27862370
[TBL] [Abstract][Full Text] [Related]
24. Beta-glucan in the diagnosis of invasive fungal disease.
Pasqualotto AC; Sukiennik TC
Clin Infect Dis; 2008 Jul; 47(2):292-3; author reply 293-4. PubMed ID: 18564936
[No Abstract] [Full Text] [Related]
25. Detection of (1,3)-β-d-Glucan for the Diagnosis of Invasive Fungal Infection in Liver Transplant Recipients.
Levesque E; Rizk F; Noorah Z; Aït-Ammar N; Cordonnier-Jourdin C; El Anbassi S; Bonnal C; Azoulay D; Merle JC; Botterel F
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28422065
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic accuracy of the 1,3-β-D-glucan test for pneumocystis pneumonia in a tertiary university hospital in Denmark: A retrospective study.
Engsbro AL; Najat S; Jørgensen KM; Kurtzhals JAL; Arendrup MC
Med Mycol; 2019 Aug; 57(6):710-717. PubMed ID: 30535059
[TBL] [Abstract][Full Text] [Related]
27. Invasive fungal infections: biomarkers and molecular approaches to diagnosis.
Schuetz AN
Clin Lab Med; 2013 Sep; 33(3):505-25. PubMed ID: 23931836
[TBL] [Abstract][Full Text] [Related]
28. Clinical evaluation of two different (1,3)-ß-d-glucan assays for diagnosis of invasive fungal diseases: A retrospective cohort study.
Zubkowicz M; Held J; Baier M; Pletz MW; Kesselmeier M; Hagel S; Bahrs C
Mycoses; 2021 Feb; 64(2):212-219. PubMed ID: 33156525
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic accuracy of serum 1,3-β-D-glucan for pneumocystis jiroveci pneumonia, invasive candidiasis, and invasive aspergillosis: systematic review and meta-analysis.
Onishi A; Sugiyama D; Kogata Y; Saegusa J; Sugimoto T; Kawano S; Morinobu A; Nishimura K; Kumagai S
J Clin Microbiol; 2012 Jan; 50(1):7-15. PubMed ID: 22075593
[TBL] [Abstract][Full Text] [Related]
30. (1 --> 3)-beta-D-glucan--a new marker for the early serodiagnosis of deep-seated fungal infections in humans.
Kedzierska A
Pol J Microbiol; 2007; 56(1):3-9. PubMed ID: 17419183
[TBL] [Abstract][Full Text] [Related]
31. Biomarkers of fungal infection: Expert opinion on the current situation.
Bouza E; Almirante B; García Rodríguez J; Garnacho-Montero J; Salavert M; Muñoz P; Sanguinetti M
Rev Esp Quimioter; 2020 Feb; 33(1):1-10. PubMed ID: 31729203
[TBL] [Abstract][Full Text] [Related]
32. (1→3)-β-D-Glucan Assay in Monitoring Response to Anti-Fungal Therapy in Fungal Endocarditis.
Slim J; Saling C; Szabela M; Brown M; Johnson T; Goldfarb I
J Heart Valve Dis; 2017 Mar; 26(2):208-210. PubMed ID: 28820552
[TBL] [Abstract][Full Text] [Related]
33. Use of (1→3)-β-d-glucan for diagnosis and management of invasive mycoses in HIV-infected patients.
Farhour Z; Mehraj V; Chen J; Ramendra R; Lu H; Routy JP
Mycoses; 2018 Oct; 61(10):718-722. PubMed ID: 29855088
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of plasma (1-->3)-beta-D-glucan measurement by the kinetic turbidimetric Limulus test, for the clinical diagnosis of mycotic infections.
Mori T; Ikemoto H; Matsumura M; Yoshida M; Inada K; Endo S; Ito A; Watanabe S; Yamaguchi H; Mitsuya M; Kodama M; Tani T; Yokota T; Kobayashi T; Kambayashi J; Nakamura T; Masaoka T; Teshima H; Yoshinaga T; Kohno S; Hara K; Miyazaki S
Eur J Clin Chem Clin Biochem; 1997 Jul; 35(7):553-60. PubMed ID: 9263735
[TBL] [Abstract][Full Text] [Related]
35. Common invasive fungal diseases: an overview of invasive candidiasis, aspergillosis, cryptococcosis, and Pneumocystis pneumonia.
Schmiedel Y; Zimmerli S
Swiss Med Wkly; 2016; 146():w14281. PubMed ID: 26901377
[TBL] [Abstract][Full Text] [Related]
36. Epidemiology and burden of invasive fungal infections in the countries of the Arab League.
Kmeid J; Jabbour JF; Kanj SS
J Infect Public Health; 2020 Dec; 13(12):2080-2086. PubMed ID: 31248814
[TBL] [Abstract][Full Text] [Related]
37. Clinical evaluation of diagnostic methods using plasma and/or serum for three mycoses: aspergillosis, candidosis, and pneumocystosis.
Mori T; Matsumura M
Nihon Ishinkin Gakkai Zasshi; 1999; 40(4):223-30. PubMed ID: 10536309
[TBL] [Abstract][Full Text] [Related]
38. Plasma (1-->3)-beta-D-glucan and fungal antigenemia in patients with candidemia, aspergillosis, and cryptococcosis.
Miyazaki T; Kohno S; Mitsutake K; Maesaki S; Tanaka K; Ishikawa N; Hara K
J Clin Microbiol; 1995 Dec; 33(12):3115-8. PubMed ID: 8586684
[TBL] [Abstract][Full Text] [Related]
39. Development of a Method of Measuring β-D-Glucan and Its Use in Preemptive Therapy for Invasive Fungal Infections.
Yoshida M
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502174
[TBL] [Abstract][Full Text] [Related]
40. Optimization of Voriconazole Therapy for the Treatment of Invasive Fungal Infections in Adults.
Mangal N; Hamadeh IS; Arwood MJ; Cavallari LH; Samant TS; Klinker KP; Bulitta J; Schmidt S
Clin Pharmacol Ther; 2018 Nov; 104(5):957-965. PubMed ID: 29315506
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
